Published in Curr Opin Immunol on September 15, 2012
The cell biology of asthma. J Cell Biol (2014) 1.40
CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma. Allergy (2016) 1.39
CCR7-dependent trafficking of RORγ⁺ ILCs creates a unique microenvironment within mucosal draining lymph nodes. Nat Commun (2015) 1.19
Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis. J Allergy Clin Immunol (2013) 1.11
Structural insights into the interaction of IL-33 with its receptors. Proc Natl Acad Sci U S A (2013) 1.09
Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness. Clin Immunol (2014) 1.06
TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol (2013) 1.02
GATA3: a master of many trades in immune regulation. Trends Immunol (2014) 0.96
Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma. Adv Biomed Res (2014) 0.89
Eosinophils in the spotlight: Finding the link between obesity and asthma. Nat Med (2013) 0.85
Dupilumab: a novel treatment for asthma. J Asthma Allergy (2014) 0.85
Diversity, function, and transcriptional regulation of gut innate lymphocytes. Front Immunol (2013) 0.83
The evolution of innate lymphoid cells. Nat Immunol (2016) 0.80
Asthma and the flu: a tricky two-step. Immunol Cell Biol (2014) 0.79
Th17/Treg ratio derived using DNA methylation analysis is associated with the late phase asthmatic response. Allergy Asthma Clin Immunol (2014) 0.79
Mechanisms of innate lymphoid cell and natural killer T cell activation during mucosal inflammation. J Immunol Res (2014) 0.79
Intrinsic functional defects of type 2 innate lymphoid cells impair innate allergic inflammation in promyelocytic leukemia zinc finger (PLZF)-deficient mice. J Allergy Clin Immunol (2015) 0.78
Biosignature for airway inflammation in a house dust mite-challenged murine model of allergic asthma. Biol Open (2016) 0.78
iNKT Cells Are Responsible for the Apoptotic Reduction of Basophils That Mediate Th2 Immune Responses Elicited by Papain in Mice Following γPGA Stimulation. PLoS One (2016) 0.77
Immune modulatory effects of IL-22 on allergen-induced pulmonary inflammation. PLoS One (2014) 0.77
The cAMP response element modulator (CREM) regulates TH2 mediated inflammation. Oncotarget (2015) 0.76
17q21 asthma-risk variants switch CTCF binding and regulate IL-2 production by T cells. Nat Commun (2016) 0.76
T lymphocyte antigen 4-modified dendritic cell therapy for asthmatic mice guided by the CCR7 chemokine receptor. Int J Mol Sci (2014) 0.76
Roles of transcriptional factor 7 in production of inflammatory factors for lung diseases. J Transl Med (2015) 0.75
Recent advances in understanding and managing asthma. F1000Res (2016) 0.75
PGI2 Controls Pulmonary NK Cells That Prevent Airway Sensitization to House Dust Mite Allergen. J Immunol (2016) 0.75
Enhanced circulating ILC2s accompany by upregulated MDSCs in patients with asthma. Int J Clin Exp Pathol (2015) 0.75
Early life exposure to environmental tobacco smoke alters immune response to asbestos via a shift in inflammatory phenotype resulting in increased disease development. Inhal Toxicol (2016) 0.75
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature (2010) 10.34
Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol (2013) 7.94
Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol (2011) 6.23
Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med (2006) 5.35
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest (2007) 4.31
Transcription factor RORα is critical for nuocyte development. Nat Immunol (2012) 3.72
Innate lymphoid cells--how did we miss them? Nat Rev Immunol (2013) 3.62
Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol (2006) 3.24
ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol (2004) 3.19
IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A (2008) 2.99
A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat Med (2009) 2.89
IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol (2008) 2.83
IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity (2002) 2.83
Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol (2011) 2.80
IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J Immunol (2007) 2.48
Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol (2007) 2.43
IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol (2007) 2.43
Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol (2011) 2.12
A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med (2013) 2.11
Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol (2007) 2.09
Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med (2002) 2.04
Direct control of hepatic glucose production by interleukin-13 in mice. J Clin Invest (2012) 1.92
Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. J Immunol (2004) 1.91
SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J Exp Med (2004) 1.73
The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway. Nat Immunol (2013) 1.70
IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol (2013) 1.70
Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity (2013) 1.67
Advances in the 5q- syndrome. Blood (2010) 1.57
IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex. J Immunol (2009) 1.54
IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J Immunol (2010) 1.52
T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation. Eur J Immunol (2007) 1.50
The IL-4/IL-13/Stat6 signalling pathway promotes luminal mammary epithelial cell development. Development (2007) 1.46
IL-33 exacerbates autoantibody-induced arthritis. J Immunol (2010) 1.40
Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J Immunol (2013) 1.38
Epithelial cell-specific Act1 adaptor mediates interleukin-25-dependent helminth expulsion through expansion of Lin(-)c-Kit(+) innate cell population. Immunity (2012) 1.34
IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur J Immunol (2012) 1.34
Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome. Hum Mol Genet (2004) 1.30
IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. Eur J Immunol (2010) 1.27
IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis. Am J Pathol (2009) 1.27
IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax (2012) 1.26
Insights into the initiation of type 2 immune responses. Immunology (2011) 1.25
Tim-1 is induced on germinal centre B cells through B-cell receptor signalling but is not essential for the germinal centre response. Immunology (2010) 1.24
Development and function of group 2 innate lymphoid cells. Curr Opin Immunol (2013) 1.24
Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. J Allergy Clin Immunol (2009) 1.22
Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. J Immunol (2006) 1.21
IL-13 regulates the immune response to inhaled antigens. J Immunol (2005) 1.19
Interleukin-13-dependent expression of matrix metalloproteinase-12 is required for the development of airway eosinophilia in mice. Am J Respir Cell Mol Biol (2003) 1.18
Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome. Blood (2010) 1.17
IL-13 is necessary, not simply sufficient, for epicutaneously induced Th2 responses to soluble protein antigen. J Immunol (2003) 1.16
IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc Natl Acad Sci U S A (2013) 1.16
Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion. J Immunol (2012) 1.15
Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity. J Exp Med (2005) 1.13
Nuocytes and beyond: new insights into helminth expulsion. Trends Parasitol (2011) 1.13
ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma. Eur J Immunol (2011) 1.10
Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M. Immunity (2002) 1.08
Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis. Microbes Infect (2006) 1.04
Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13. J Gastroenterol (2012) 1.04
Nuocytes: expanding the innate cell repertoire in type-2 immunity. J Leukoc Biol (2011) 1.03
Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells. J Bone Miner Res (2011) 1.02
IL-33 activates B1 cells and exacerbates contact sensitivity. J Immunol (2011) 1.01
A critical role of SHP-1 in regulation of type 2 inflammation in the lung. Am J Respir Cell Mol Biol (2008) 1.01
Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease. Exp Hematol (2008) 1.00
An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection. Eur J Immunol (2002) 0.96
C-type lectin SIGN-R1 has a role in experimental colitis and responsiveness to lipopolysaccharide. J Immunol (2010) 0.95
IL-25: a key requirement for the regulation of type-2 immunity. Biofactors (2009) 0.92
Granulocyte macrophage colony-stimulating factor-driven respiratory mucosal sensitization induces Th2 differentiation and function independently of interleukin-4. Am J Respir Cell Mol Biol (2002) 0.90
New insights into 5q- syndrome as a ribosomopathy. Cell Cycle (2010) 0.89
Type-2 innate lymphoid cells in human allergic disease. Curr Opin Allergy Clin Immunol (2014) 0.89
Eotaxin expression by epithelial cells and plasma cells in chronic asthma. Lab Invest (2002) 0.89
Complete inhibition of allergic airway inflammation and remodelling in quadruple IL-4/5/9/13-/- mice. Clin Exp Allergy (2007) 0.88
The C-type lectin SIGNR1 binds Schistosoma mansoni antigens in vitro, but SIGNR1-deficient mice have normal responses during schistosome infection. Infect Immun (2008) 0.88
Innate lymphoid cells in immunity and disease. Adv Exp Med Biol (2013) 0.87
Pulmonary suppressor of cytokine signaling-1 induced by IL-13 regulates allergic asthma phenotype. Am J Respir Crit Care Med (2009) 0.86
ST2 deficient mice display a normal host defense against pulmonary infection with Mycobacterium tuberculosis. Microbes Infect (2009) 0.85
TH9 cell generation. TH9: the latest addition to the expanding repertoire of IL-25 targets. Immunol Cell Biol (2010) 0.84
Lymphomagenesis, hydronephrosis, and autoantibodies result from dysregulation of IL-9 and are differentially dependent on Th2 cytokines. J Immunol (2004) 0.83
A Trypanosoma brucei kinesin heavy chain promotes parasite growth by triggering host arginase activity. PLoS Pathog (2013) 0.82
Polymorphisms in IL-4R alpha correlate with airways hyperreactivity, eosinophilia, and Ym protein expression in allergic IL-13-/- mice. J Immunol (2004) 0.80
The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice. Am J Pathol (2012) 0.80
Measurement of interleukin-13. Curr Protoc Immunol (2002) 0.77
Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest (2017) 0.75